CNP and stroke disorder: APX3330 treatment also significantly increases oligodendrocyte (CNPase, p<0.05, n=7/group, Fig. 3C) and oligodendrocyte progenitor cell density (NG2, p<0.05, n=7/group, Fig. 3D) in the IBZ compared to PBS treated control T1DM stroke rats.